EnvoyAI Partner:

Year Founded: 2011
Area of Focus/Speciality: Breast imaging analytics (workflow performance, mammography quality, breast density)
Company Headquarters: Halifax, Nova Scotia, Canada
Number of Algorithms:  1
Densitas linkedin page
Densitas twitter profile


About Densitas

Densitas is developing an advanced imaging analytics platform powered by machine learning algorithms that delivers actionable insights at point-of-care for high quality personalized breast health. The technologies address the key challenges facing breast screening today, including mammography quality, workflow performance, compliance and costs with the aim of improving patient outcomes.

Densitas’ zero-click automated breast density assessment software, densitasdensity™, analyzes the same standard digital mammograms that radiologists view. The solution integrates seamlessly with PACS systems. And the insights generated by the software empower radiologists to make the most appropriate follow-up care decisions consistently and confidently at unrivaled speeds


Reference Sites:

  • Select hospitals and clinics. References available upon request.

End-User Testimonials


“The integration of DENSITAS|density into our clinical workflow was seamless. The Densitas breast density reports arrive alongside the mammography exams on our PACS nearly simultaneously. They are clear and easy to reference.”

Dr. Sian Iles, Section Head, Breast Imaging, Central Zone, Nova Scotia Health Authority


“The breast density measurements generated by DENSITAS|density match my visual estimates closely. I have confidence in the reproducibility and consistency of the density measurement, and this is fundamental if decisions within breast screening programs about screening frequency or ancillary screening methods are made based on a woman’s breast density.”

Dr. Sian Iles, Section Head, Breast Imaging, Central Zone, Nova Scotia Health Authority

PACS Admin

“The flexibility of DENSITAS|density’s configuration permitted seamless and rapid integration of the software into our workflow. Densitas continues to provide exceptional customer service. We look forward to working with them on new initiatives in the future.”

Nina R. PACS Admin, Central Zone, Nova Scotia Health Authority

Densitas Leadership
Mohamed Abdolell CEO and Founder Densitas Inc

Mohamed Abdolell

CEO and Founder

Dr Jae Kim MD PhD FRCPC Founding Director of Sentinelle Medical

Dr. Jae Kim, MD, PhD, FRCPC

Founding Director of Sentinelle Medical

Michael Lee, General Partner, Rogers Venture Partners

Michael Lee

General Partner, Rogers Venture Partners

Dr Caines, Founding Medical Director, Nova Scotia Breast Screening Program

Dr. Caines

Founding Medical Director, Nova Scotia Breast Screening Program

Densitas Machine | DENSITAS|density™

Densitas is directly responsible for product and clinical representations

  • densitas AI Machine
  • densitas AI Machine
  • Densitas1.png
  • Densitas2.png
  • Densitas3.png

For illustrative purposes only. Actual report details may vary based on regulatory requirements, product version, and customer configuration preferences.

DENSITAS|density™ is an advanced machine learning application that provides automated point-of-care breast density assessments for high quality personalized breast care. DENSITAS|density’s zero-click reports provide near instant access to breast density classification grades per the American College of Radiology’s BI-RADS 4th or 5th Edition density scales along with percent density, breast area, and dense area measures. 

Data are calculated by analyzing the pixel data associated with standard digital mammograms generated by compatible digital mammography systems. The reports are displayed on the radiologists’ workstations along with the digital mammogram. Breast density is an important factor associated with cancer risk and affects the sensitivity of mammography. It is an important factor in determining followup screening protocols, triaging women to adjunct imaging and frequency of followup screening visits . These measures give radiologists on demand availability of standardized and reliably reproducible breast density estimates, empowering them to make high quality patient-specific follow-up care decisions quickly and confidently to optimize health outcomes and boost workflow performance. DENSITAS|density   integrates seamlessly with PACS systems.

  • Applicable Study Types: Standard processed DICOM full field digital screening mammograms
    (our DENSITAS|density software analyzes mammograms generated by
    compatible FFDMs)
  • Training Data Source: Standard screening digital mammograms from the Nova Scotia Health Authority
  • Regulatory Status:
    • DENSITAS|density™ is available for clinical use in the USA, EU, Canada and Australia:
      • FDA Cleared (USA)
      • CE-marked (EU)
      • Health Canada licensed (CAN)
      • TGA registered (AUS)